Identification of Alternative Substrates of Pregnancy-Associated Plasma Protein-A

妊娠相关血浆蛋白 A 替代底物的鉴定

基本信息

  • 批准号:
    7515599
  • 负责人:
  • 金额:
    $ 18.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-01 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Pregnancy Associated Plasma Protein-A (PAPP-A) was identified in 1974 as one of four protein markers in normal human pregnancy serum. PAPP-A is a metalloprotease that cleaves Insulin-like Growth Factor Binding Protein-4 (IGFBP-4) into 2 fragments. This cleavage causes the release of IGFs from IGFBP-4 sequestration and allows the Insulinlike Growth Factors (IGFs) to bind to the cell surface IGF receptor. Thus PAPP-A is an important regulator of IGF bioavailability. Since this discovery, PAPP-A has been implicated in a variety of biological systems including fetal development, bone remodeling, wound healing, atherosclerosis, acute coronary syndrome, aging and cancer. In spite of the fact that PAPP-A has been aggressively studied in the past, there is very little evidence to directly implicate PAPP-A or it's proteolytic activity in biological systems other than the IGFs. The purpose of this application is to probe samples from mouse PAPP-A null and wild-type tissue using open ended proteomic tools in order to determine if PAPP-A cleaves proteins other than IGFBP-4 in biological systems. Specifically we will use two dimensional gel electrophoresis and liquid chromatography to compare the protein expression pattern of the PAPP-A null tissue against the protein expression pattern of the wild-type tissue. Any protein expression differences discovered are likely to be the direct or indirect result of PAPP-A proteolytic activity. The proteins with altered expression will be identified. The information gained from the identification of these proteins will suggest novel biological roles for PAPP-A and may lead to the direct link between PAPP-A and human diseases. PUBLIC HEALTH RELEVANCE: Pregnancy-Associated Plasma Protein-A (PAPP-A) is an important modulator of Insulin- like Growth Factor signaling. PAPP-A has been implicated in several human biological systems, including atherosclerosis, acute coronary syndrome, aging and cancer, however direct evidence of PAPP-A proteolytic activity in these systems is lacking. This goal of this application is to investigate and discover a direct link between PAPP-A proteolytic activity and known or novel biological systems.
描述(由申请人提供):妊娠相关血浆蛋白-A(PAPP-A)于1974年被鉴定为正常人妊娠血清中的四种蛋白质标志物之一。PAPP-A是一种金属蛋白酶,可将胰岛素样生长因子结合蛋白-4(IGFBP-4)切割成2个片段。这种切割导致IGFs从IGFBP-4隔离中释放,并允许胰岛素样生长因子(IGFs)与细胞表面IGF受体结合。因此,PAPP-A是IGF生物利用度的重要调节剂。自这一发现以来,PAPP-A已涉及多种生物系统,包括胎儿发育、骨重塑、伤口愈合、动脉粥样硬化、急性冠状动脉综合征、衰老和癌症。尽管PAPP-A在过去已经被积极地研究,但很少有证据直接涉及PAPP-A或其在IGFs以外的生物系统中的蛋白水解活性。本申请的目的是使用开放式蛋白质组学工具探测来自小鼠PAPP-A无效和野生型组织的样品,以确定PAPP-A是否切割生物系统中除IGFBP-4以外的蛋白质。具体而言,我们将使用二维凝胶电泳和液相色谱法来比较PAPP-A无效组织的蛋白表达模式与野生型组织的蛋白表达模式。发现的任何蛋白质表达差异可能是PAPP-A蛋白水解活性的直接或间接结果。将鉴定表达改变的蛋白质。从这些蛋白质的鉴定中获得的信息将提示PAPP-A的新生物学作用,并可能导致PAPP-A与人类疾病之间的直接联系。公共卫生相关性:妊娠相关血浆蛋白A(PAPP-A)是胰岛素样生长因子信号传导的重要调节剂。PAPP-A与多种人类生物系统有关,包括动脉粥样硬化、急性冠状动脉综合征、衰老和癌症,然而缺乏PAPP-A在这些系统中蛋白水解活性的直接证据。本申请的目的是研究和发现PAPP-A蛋白水解活性与已知或新的生物系统之间的直接联系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James Lawrence其他文献

James Lawrence的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James Lawrence', 18)}}的其他基金

FMRI OF PAIN MODULATION BY COGNITIVE BEHAVIORAL STRATEGIES
通过认知行为策略调节疼痛的 FMRI
  • 批准号:
    8169860
  • 财政年份:
    2010
  • 资助金额:
    $ 18.38万
  • 项目类别:
FMRI OF PAIN MODULATION BY COGNITIVE BEHAVIORAL STRATEGIES
通过认知行为策略调节疼痛的 FMRI
  • 批准号:
    7955386
  • 财政年份:
    2009
  • 资助金额:
    $ 18.38万
  • 项目类别:
FMRI OF PAIN MODULATION BY COGNITIVE BEHAVIORAL STRATEGIES
通过认知行为策略调节疼痛的 FMRI
  • 批准号:
    7722933
  • 财政年份:
    2008
  • 资助金额:
    $ 18.38万
  • 项目类别:

相似海外基金

Establishment of a method for the treatment of atherosclerosis and vascular aging using GLP-1 receptor agonists and SGLT2 inhibitors
GLP-1受体激动剂和SGLT2抑制剂治疗动脉粥样硬化和血管老化方法的建立
  • 批准号:
    23K06857
  • 财政年份:
    2023
  • 资助金额:
    $ 18.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inflammation-resolution impairments in aging and atherosclerosis
衰老和动脉粥样硬化中的炎症消退障碍
  • 批准号:
    10724859
  • 财政年份:
    2023
  • 资助金额:
    $ 18.38万
  • 项目类别:
8OH-G miR-483 contributes to the aging-accelerated atherosclerosis
8OH-G miR-483 有助于衰老加速的动脉粥样硬化
  • 批准号:
    10452425
  • 财政年份:
    2022
  • 资助金额:
    $ 18.38万
  • 项目类别:
8OH-G miR-483 contributes to the aging-accelerated atherosclerosis
8OH-G miR-483 有助于衰老加速的动脉粥样硬化
  • 批准号:
    10793303
  • 财政年份:
    2022
  • 资助金额:
    $ 18.38万
  • 项目类别:
Interaction between the endocannabinoid system and inflamm-aging : implication in accelerated atherosclerosis in people living with HIV under ART
内源性大麻素系统与炎症衰老之间的相互作用:ART 治疗下 HIV 感染者加速动脉粥样硬化的影响
  • 批准号:
    486649
  • 财政年份:
    2022
  • 资助金额:
    $ 18.38万
  • 项目类别:
    Studentship Programs
Premature aging disorders, metabolites, and atherosclerosis
过早衰老疾病、代谢产物和动脉粥样硬化
  • 批准号:
    10607893
  • 财政年份:
    2022
  • 资助金额:
    $ 18.38万
  • 项目类别:
Influence of sleep on the hematopoietic niche and atherosclerosis during aging
睡眠对衰老过程中造血生态位和动脉粥样硬化的影响
  • 批准号:
    10270515
  • 财政年份:
    2021
  • 资助金额:
    $ 18.38万
  • 项目类别:
Influence of sleep on the hematopoietic niche and atherosclerosis during aging
睡眠对衰老过程中造血生态位和动脉粥样硬化的影响
  • 批准号:
    10618378
  • 财政年份:
    2021
  • 资助金额:
    $ 18.38万
  • 项目类别:
Influence of sleep on the hematopoietic niche and atherosclerosis during aging
睡眠对衰老过程中造血生态位和动脉粥样硬化的影响
  • 批准号:
    10440470
  • 财政年份:
    2021
  • 资助金额:
    $ 18.38万
  • 项目类别:
Elucidation of molecular basis for the relationship between periodontal disease and atherosclerosis by controlling aging
通过控制衰老阐明牙周病与动脉粥样硬化关系的分子基础
  • 批准号:
    18K09611
  • 财政年份:
    2018
  • 资助金额:
    $ 18.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了